|
| 复星医药(600196)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2024-12-13 | 82.55 | 0.03% | 267144.06 | 95.81 | 211771.47 | 79.24% | 股权激励限售股份 | | 2024-09-23 | 18.58 | 0.01% | 267061.51 | 178.36 | 211771.47 | 79.24% | 股权激励限售股份 | | 2024-01-16 | 77.41 | 0.03% | 267042.93 | 196.94 | 211771.47 | 79.24% | 股权激励限售股份 | | 2023-01-30 | 10675.67 | 4.00% | 266965.52 | 250.14 | 211771.47 | 79.25% | 定向增发机构配售股份 | | 2019-11-08 | 10043.67 | 3.92% | 201095.80 | 0.00 | 201095.80 | 78.46% | 增发A股法人配售上市 | | 2018-11-30 | 71.23 | 0.03% | 191052.14 | 10059.90 | 201112.04 | 78.47% | 股权激励限售流通 | | 2017-11-29 | 83.57 | 0.03% | 190980.91 | 10138.15 | 201119.05 | 80.60% | 股权激励限售流通 | | 2017-01-19 | 125.94 | 0.05% | 190897.33 | 10225.47 | 201122.80 | 83.30% | 股权激励限售流通 | | 2016-12-06 | 87.70 | 0.04% | 190771.40 | 10351.41 | 201122.80 | 83.30% | 股权激励限售流通 | | 2016-01-14 | 122.23 | 0.05% | 190683.70 | 395.44 | 191079.14 | 82.57% | 股权激励限售流通 | | 2015-02-25 | 122.23 | 0.05% | 190561.47 | 248.17 | 190809.64 | 82.55% | 股权激励限售流通 | | 2013-05-06 | 477.30 | 0.21% | 190439.24 | 0.00 | 190439.24 | 85.00% | 增发A股法人配售上市 | | 2011-05-04 | 4295.70 | 2.26% | 189961.94 | 477.30 | 190439.24 | 100.00% | 增发A股法人配售上市 | | 2011-04-26 | 74602.78 | 39.17% | 185666.24 | 4773.00 | 190439.24 | 100.00% | 股权分置限售流通 | | 2010-04-26 | 5477.39 | 4.43% | 74042.31 | 49735.18 | 123777.49 | 100.00% | 股权分置限售流通 | | 2009-04-27 | 5477.39 | 4.43% | 68564.91 | 55212.58 | 123777.49 | 100.00% | 股权分置限售流通 | | 2007-04-26 | 443.01 | 0.47% | 48528.86 | 46684.59 | 95213.45 | 100.00% | 股权分置限售流通 |
|